PortfoliosLab logoPortfoliosLab logo
BIOX vs. ALTO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BIOX vs. ALTO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bioceres Crop Solutions Corp. (BIOX) and Alto Ingredients, Inc. (ALTO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BIOX achieves a -64.93% return, which is significantly lower than ALTO's 92.01% return.


BIOX

1D
-6.34%
1M
2.87%
YTD
-64.93%
6M
-71.11%
1Y
-90.81%
3Y*
-66.93%
5Y*
-49.68%
10Y*

ALTO

1D
-2.47%
1M
1.10%
YTD
92.01%
6M
97.50%
1Y
482.53%
3Y*
37.87%
5Y*
-1.68%
10Y*
-1.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BIOX vs. ALTO - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
BIOX
Bioceres Crop Solutions Corp.
-64.93%-78.45%-55.72%14.13%-14.92%128.06%22.80%-49.86%4.90%
ALTO
Alto Ingredients, Inc.
92.01%84.62%-41.35%-7.64%-40.12%-11.42%735.38%-24.51%-73.91%

Correlation

The correlation between BIOX and ALTO is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Mar 23, 2018

0.14

Fundamentals

Market Cap

BIOX:

$29.22M

ALTO:

$423.81M

EPS

BIOX:

-$3.84

ALTO:

$0.38

PS Ratio

BIOX:

0.11

ALTO:

0.46

Total Revenue (TTM)

BIOX:

$263.71M

ALTO:

$916.07M

Gross Profit (TTM)

BIOX:

$97.66M

ALTO:

$45.94M

EBITDA (TTM)

BIOX:

-$1.32M

ALTO:

$20.37M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIOX vs. ALTO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOX
BIOX Risk / Return Rank: 55
Overall Rank
BIOX Sharpe Ratio Rank: 77
Sharpe Ratio Rank
BIOX Sortino Ratio Rank: 11
Sortino Ratio Rank
BIOX Omega Ratio Rank: 22
Omega Ratio Rank
BIOX Calmar Ratio Rank: 22
Calmar Ratio Rank
BIOX Martin Ratio Rank: 1111
Martin Ratio Rank

ALTO
ALTO Risk / Return Rank: 9898
Overall Rank
ALTO Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
ALTO Sortino Ratio Rank: 9696
Sortino Ratio Rank
ALTO Omega Ratio Rank: 9696
Omega Ratio Rank
ALTO Calmar Ratio Rank: 9999
Calmar Ratio Rank
ALTO Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIOX vs. ALTO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bioceres Crop Solutions Corp. (BIOX) and Alto Ingredients, Inc. (ALTO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIOXALTODifference
Sharpe ratioReturn per unit of total volatility

-5.96

Sortino ratioReturn per unit of downside risk

-6.87

Omega ratioGain probability vs. loss probability

0.73

1.64

-0.90

Calmar ratioReturn relative to maximum drawdown

-0.98

17.00

-17.98

Martin ratioReturn relative to average drawdown

-1.30

39.94

-41.24

BIOX vs. ALTO - Sharpe Ratio Comparison

The current BIOX Sharpe Ratio is -0.89, which is lower than the ALTO Sharpe Ratio of 5.07. The chart below compares the historical Sharpe Ratios of BIOX and ALTO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BIOXALTODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.89

5.07

-5.96

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.78

-0.02

-0.76

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.48

-0.21

-0.27

Drawdowns

BIOX vs. ALTO - Drawdown Comparison

The maximum BIOX drawdown since its inception was -97.68%, roughly equal to the maximum ALTO drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for BIOX and ALTO.


Loading charts...

Drawdown Indicators


BIOXALTODifference

Max Drawdown

Largest peak-to-trough decline

-97.68%

-99.99%

+2.31%

Max Drawdown (1Y)

Largest decline over 1 year

-92.66%

-28.62%

-64.04%

Max Drawdown (3Y)

Largest decline over 3 years

-97.33%

-84.11%

-13.22%

Max Drawdown (5Y)

Largest decline over 5 years

-97.68%

-89.12%

-8.56%

Max Drawdown (10Y)

Largest decline over 10 years

-97.77%

Current Drawdown

Current decline from peak

-97.13%

-99.88%

+2.75%

Average Drawdown

Average peak-to-trough decline

-36.08%

-92.32%

+56.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

69.65%

12.16%

+57.49%

Volatility

BIOX vs. ALTO - Volatility Comparison

Bioceres Crop Solutions Corp. (BIOX) has a higher volatility of 32.05% compared to Alto Ingredients, Inc. (ALTO) at 30.02%. This indicates that BIOX's price experiences larger fluctuations and is considered to be riskier than ALTO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BIOXALTODifference

Volatility (1M)

Calculated over the trailing 1-month period

32.05%

30.02%

+2.03%

Volatility (6M)

Calculated over the trailing 6-month period

83.83%

68.58%

+15.25%

Volatility (1Y)

Calculated over the trailing 1-year period

102.46%

95.99%

+6.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.21%

79.46%

-15.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

64.99%

90.65%

-25.66%

Dividends

BIOX vs. ALTO - Dividend Comparison

Neither BIOX nor ALTO has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

BIOX vs. ALTO - Financials Comparison

This section allows you to compare key financial metrics between Bioceres Crop Solutions Corp. and Alto Ingredients, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
38.20M
224.68M
(BIOX) Total Revenue
(ALTO) Total Revenue
Values in USD except per share items

BIOX vs. ALTO - Profitability Comparison

The chart below illustrates the profitability comparison between Bioceres Crop Solutions Corp. and Alto Ingredients, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%20222023202420252026
30.1%
4.1%
Portfolio components
BIOX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioceres Crop Solutions Corp. reported a gross profit of 11.50M and revenue of 38.20M. Therefore, the gross margin over that period was 30.1%.

ALTO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported a gross profit of 9.22M and revenue of 224.68M. Therefore, the gross margin over that period was 4.1%.

BIOX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioceres Crop Solutions Corp. reported an operating income of -6.50M and revenue of 38.20M, resulting in an operating margin of -17.0%.

ALTO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported an operating income of 2.52M and revenue of 224.68M, resulting in an operating margin of 1.1%.

BIOX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioceres Crop Solutions Corp. reported a net income of -8.90M and revenue of 38.20M, resulting in a net margin of -23.3%.

ALTO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported a net income of 3.96M and revenue of 224.68M, resulting in a net margin of 1.8%.


Frequently Asked Questions


BIOX and ALTO have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BIOX has higher volatility (32.05%) compared to ALTO (30.02%). In terms of maximum drawdown, BIOX dropped -97.68% vs ALTO's -99.99%.

ALTO currently has the higher Sharpe Ratio (5.07 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BIOX and ALTO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer